SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Xylem Inc. – ‘10-Q’ for 3/31/20 – ‘EX-31.1’

On:  Tuesday, 5/5/20, at 1:28pm ET   ·   For:  3/31/20   ·   Accession #:  1524472-20-20   ·   File #:  1-35229

Previous ‘10-Q’:  ‘10-Q’ on 10/31/19 for 9/30/19   ·   Next:  ‘10-Q’ on 7/30/20 for 6/30/20   ·   Latest:  ‘10-Q’ on 5/2/24 for 3/31/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 5/05/20  Xylem Inc.                        10-Q        3/31/20   95:12M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.05M 
 2: EX-10.35    Material Contract                                   HTML    163K 
 3: EX-10.36    Material Contract                                   HTML     82K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     32K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     32K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     28K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     28K 
24: R1          Cover Page                                          HTML     84K 
71: R2          Recently Issued Accounting Pronouncements           HTML     29K 
82: R3          Condensed Consolidated Income Statements            HTML     83K 
                (Unaudited)                                                      
53: R4          Condensed Consolidated Statements of Comprehensive  HTML     74K 
                (Loss) Income (Unaudited)                                        
22: R5          Condensed Consolidated Balance Sheets (Unaudited)   HTML    118K 
69: R6          Condensed Consolidated Balance Sheets (Unaudited)   HTML     38K 
                (Parenthetical)                                                  
80: R7          Condensed Consolidated Statements of Cash Flows     HTML    109K 
                (Unaudited)                                                      
55: R8          Restructuring Charges                               HTML    136K 
20: R9          Background and Basis of Presentation                HTML     33K 
95: R10         Acquisitions and Divestitures                       HTML     29K 
65: R11         Revenue                                             HTML    122K 
31: R12         Income Taxes                                        HTML     31K 
42: R13         Earnings Per Share                                  HTML     60K 
94: R14         Inventories                                         HTML     36K 
64: R15         Goodwill and Other Intangible Assets                HTML     86K 
30: R16         Derivative Financial Instruments                    HTML     71K 
41: R17         Accrued and Other Current Liabilities               HTML     41K 
93: R18         Credit Facilities and Debt                          HTML     65K 
66: R19         Postretirement Benefit Plans                        HTML     58K 
15: R20         Equity                                              HTML    160K 
48: R21         Share-Based Compensation Plans                      HTML    104K 
77: R22         Capital Stock                                       HTML     30K 
68: R23         Accumulated Other Comprehensive Income (Loss)       HTML    111K 
13: R24         Commitments and Contingencies                       HTML     49K 
47: R25         Segment Information                                 HTML     87K 
76: R26         Background and Basis of Presentation (Policies)     HTML     34K 
67: R27         Restructuring Charges (Tables)                      HTML    137K 
16: R28         Revenue (Tables)                                    HTML    121K 
46: R29         Earnings Per Share (Tables)                         HTML     60K 
43: R30         Inventories (Tables)                                HTML     38K 
33: R31         Goodwill and Other Intangible Assets (Tables)       HTML     87K 
62: R32         Derivative Financial Instruments (Tables)           HTML     65K 
91: R33         Accrued and Other Current Liabilities (Tables)      HTML     41K 
44: R34         Credit Facilities and Debt (Tables)                 HTML     53K 
34: R35         Postretirement Benefit Plans (Tables)               HTML     55K 
63: R36         Equity (Tables)                                     HTML    161K 
92: R37         Share-Based Compensation Plans (Tables)             HTML    109K 
45: R38         Accumulated Other Comprehensive Income (Loss)       HTML    110K 
                (Tables)                                                         
32: R39         Commitments and Contingencies (Tables)              HTML     39K 
49: R40         Segment Information (Tables)                        HTML     83K 
18: R41         Background and Basis of Presentation (Details)      HTML     27K 
74: R42         Acquisitions and Divestitures (Textuals) (Details)  HTML     27K 
84: R43         Restructuring Charges (Textuals) (Details)          HTML     35K 
50: R44         Restructuring Charges (Restructuring Charges)       HTML     49K 
                (Details)                                                        
19: R45         Restructuring Charges (Accrual Rollfoward)          HTML     49K 
                (Details)                                                        
75: R46         Restructuring Charges (Estimated Restructuring      HTML     67K 
                Costs) (Details)                                                 
85: R47         Revenue - Disaggregation of Revenue (Details)       HTML     74K 
51: R48         Revenue (Details)                                   HTML     45K 
17: R49         Revenue (Narrative) (Details)                       HTML     33K 
26: R50         Income Taxes (Textuals) (Details)                   HTML     45K 
38: R51         Earnings Per Share (Calculations for EPS)           HTML     68K 
                (Details)                                                        
89: R52         Earnings Per Share (Summary of Antidilutive         HTML     35K 
                Securities) (Details)                                            
61: R53         Inventories (Details)                               HTML     37K 
25: R54         Goodwill and Other Intangible Assets (Goodwill      HTML     38K 
                Rollforward) (Details)                                           
36: R55         Goodwill and Other Intangible Assets (Summary of    HTML     59K 
                Intangible Assets) (Details)                                     
88: R56         Goodwill and Other Intangible Assets (Details       HTML     31K 
                Textual)                                                         
60: R57         Derivative Financial Instruments (Effect of         HTML     47K 
                Deriative Instruments on Income Statement and                    
                Statement of Comprehensive Income) (Details)                     
27: R58         Derivative Financial Instruments (Balance Sheet     HTML     39K 
                Location of Derivative Instruments) (Details)                    
35: R59         Derivative Financial Instruments (Details Textual)  HTML     66K 
83: R60         Accrued and Other Current Liabilities (Details)     HTML     45K 
72: R61         Credit Facilities and Debt (Summary of Debt         HTML     53K 
                Outstanding) (Details)                                           
23: R62         Credit Facilities and Debt (Textuals) (Details)     HTML    144K 
54: R63         Postretirement Benefit Plans (Summary of Net        HTML     47K 
                Periodic Benefit Cost) (Details)                                 
81: R64         Postretirement Benefit Plans (Textuals) (Details)   HTML     52K 
70: R65         Equity - Summary of Shareholders' Equity (Details)  HTML     84K 
21: R66         Share-Based Compensation Plans (Textuals)           HTML     52K 
                (Details)                                                        
52: R67         Share-Based Compensation Plans (Summary of Stock    HTML     79K 
                Options Grant) (Details)                                         
79: R68         Share-Based Compensation Plans (Stock Option Fair   HTML     40K 
                Value Assumptions) (Details)                                     
73: R69         Share-Based Compensation Plans (Summary of          HTML     51K 
                Restricted Stock Unit Grants) (Details)                          
57: R70         Share-Based Compensation Plans Share-Based          HTML     53K 
                Compensation Plans (Summary of ROIC Performance                  
                Share Unit Grants) (Details)                                     
86: R71         Share-Based Compensation Plans (Summary of          HTML     57K 
                Performance-Based Share Grants) (Details)                        
39: R72         Share-Based Compensation Plans (TSR                 HTML     39K 
                Performance-Based Shares Fair Value Assumptions)                 
                (Details)                                                        
28: R73         Capital Stock (Textuals) (Details)                  HTML     44K 
58: R74         Accumulated Other Comprehensive Income (Loss)       HTML     79K 
                (Details)                                                        
87: R75         Commitments and Contingencies (Summary of           HTML     35K 
                Warranties) (Details)                                            
40: R76         Commitments and Contingencies (Details Textual)     HTML     33K 
29: R77         Segment Information (Summary of Operations by       HTML     65K 
                Segment) (Details)                                               
56: R78         Segment Information (Textuals) (Details)            HTML     27K 
37: XML         IDEA XML File -- Filing Summary                      XML    174K 
90: XML         XBRL Instance -- xyl-20200331_htm                    XML   3.06M 
14: EXCEL       IDEA Workbook of Financial Reports                  XLSX     88K 
 9: EX-101.CAL  XBRL Calculations -- xyl-20200331_cal                XML    218K 
10: EX-101.DEF  XBRL Definitions -- xyl-20200331_def                 XML    728K 
11: EX-101.LAB  XBRL Labels -- xyl-20200331_lab                      XML   1.66M 
12: EX-101.PRE  XBRL Presentations -- xyl-20200331_pre               XML   1.06M 
 8: EX-101.SCH  XBRL Schema -- xyl-20200331                          XSD    167K 
59: JSON        XBRL Instance as JSON Data -- MetaLinks              365±   554K 
78: ZIP         XBRL Zipped Folder -- 0001524472-20-000020-xbrl      Zip    364K 


‘EX-31.1’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

EXHIBIT 31.1
CERTIFICATION PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Patrick K. Decker, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Xylem Inc. for the period ended March 31, 2020;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 5, 2020
/s/ Patrick K. Decker
President and Chief Executive Officer



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:5/5/208-K
For Period end:3/31/208-K
 List all Filings 
Top
Filing Submission 0001524472-20-000020   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 12:04:46.1am ET